dalteparin has been researched along with Retinal Diseases in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Retinal Diseases: Diseases involving the RETINA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beato, J | 1 |
Fígueira, L | 1 |
Penas, S | 1 |
Santos-Silva, R | 1 |
Falcão, M | 1 |
Carneiro, Â | 1 |
Reis, FF | 1 |
Bick, RL | 1 |
Alfar, H | 1 |
Goedecke, C | 1 |
Aggermann, T | 1 |
Haas, P | 1 |
Binder, S | 1 |
3 other studies available for dalteparin and Retinal Diseases
Article | Year |
---|---|
Presumed bilateral cilioretinal artery occlusion related to relapsing white dot syndrome.
Topics: Arterial Occlusive Diseases; Aspirin; Ciliary Arteries; Coloring Agents; Drug Therapy, Combination; | 2016 |
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Da | 2002 |
Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome.
Topics: Dalteparin; Fibrinolytic Agents; Fundus Oculi; Humans; Livedo Reticularis; Male; Middle Aged; Pentox | 2007 |